Ensysce Biosciences (ENSCW) Current Assets (2017 - 2025)

Ensysce Biosciences (ENSCW) has 9 years of Current Assets data on file, last reported at $7.2 million in Q4 2025.

• Current Assets for Q4 2025 came in at $7.2 million, up 35.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.2 million (up 35.56% YoY), and the FY2025 annual result was $7.2 million, up 35.56% from the prior year.
• Current Assets advanced to $7.2 million in Q4 2025 per ENSCW's latest filing, from $2.9 million in the prior quarter.
• Over five years, Current Assets peaked at $15.7 million in Q4 2021 and troughed at $228213.0 in Q1 2021.
• A 5-year average of $6.0 million and a median of $5.3 million in 2022 frame the typical range for Current Assets.
• The sharpest annual moves came in 2021 and 2023: Current Assets jumped 8662.1% in 2021, then plunged 71.09% in 2023.
• A 5-year view of Current Assets shows it stood at $15.7 million in 2021, then tumbled by 66.17% to $5.3 million in 2022, then slumped by 56.81% to $2.3 million in 2023, then jumped by 133.51% to $5.3 million in 2024, then surged by 35.56% to $7.2 million in 2025.
• Business Quant data shows ENSCW's Current Assets at $7.2 million in Q4 2025, $2.9 million in Q3 2025, and $5.3 million in Q2 2025.